Neovacs

Neovacs forms U.S. subsidiary

Wednesday, March 25, 2015

Neovacs, a Paris-based biotechnology company focused on autoimmune and inflammatory diseases, has established a wholly-owned U.S. subsidiary, Neovacs Inc. Neovacs Inc. is headquartered in Boston and has been incorporated in Delaware.

[Read More]